期刊文献+

胰腺移植的研究进展

Current status of pancreas transplantation
下载PDF
导出
摘要 胰腺移植是治疗终末期糖尿病的可行性选择.40来,外科手术技术及免疫抑制的进步,显著促进了胰腺移植适应证的增加和移植物存活率的提高.胰腺移植能替代患者每天的胰岛素注射,提高生活质量,同时也需要复杂的手术操作和终生的免疫抑制治疗.因此发展创伤更小的内分泌替代治疗方法(胰岛移植)的研究一直在进行.本文概括地介绍了胰腺移植的适应证、供体选择、手术技术、免疫抑制和排斥的现状. Pancreas transplantation has emerged as the treatment of choice for patients with end-stage diabetes mellitus. Over the last four decades, many improvements have been made in the surgical techniques and immunosuppressive regi- mens, which contributed to increased number of indications and improved allograft survival. Pancreas transplantation can be justifi ed on the basis that patients replace daily injections of insulin with an improved quality of life but at the expense of a major surgical procedure with a relatively higher complication rate, and lifelong immunosuppression. Therefore, efforts to develop more minimally invasive techniquesfor endocrine replacement therapy such as islet transplantation have been in progress. This article summarizes the current understanding of pancreas transplantation-associated indications, donor selection, surgical techniques, immuno- suppression, and rejection.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第16期1651-1658,共8页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.30801127 辽宁省教育厅课题基金资助项目 No.2004F088~~
关键词 胰腺移植 供体 手术技术 排斥 免疫抑制 Pancreas transplantation Donor Surgical technique Rejection Immunosuppression
  • 相关文献

参考文献64

  • 1Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967; 61: 827-837.
  • 2The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
  • 3Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
  • 4Tydén G, Reinholt FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335: 860-863.
  • 5明长生,陈孝平.中国胰肾联合移植现状[J].肝胆胰外科杂志,2008,20(3):153-155. 被引量:15
  • 6郑树森.胰腺移植的适应症和展望[J].胰腺病学,2002,2(3):131-132. 被引量:8
  • 7Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19: 433-455.
  • 8Gruessner RW, Sutherland DE, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2004; 4: 2018-2026.
  • 9Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, Mauer SM, Kennedy WR, Goetz FC, Robertson RP, Gruessner AC, Najarian JS. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463-501.
  • 10Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69-75.

二级参考文献32

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部